Daily Medication Pearl: Privigen Immune Globulin Intravenous (Human)
July 22nd 2022Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.
Read More
Daily Medication Pearl: Dronabinol (Syndros)
July 21st 2022Dronabinol (Syndros) is a cannabinoid indicated in adults for the treatment of: anorexia associated with weight loss in patients with AIDS and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
Read More
Dupixent Shows Positive Results for Children Under 12 with Eosinophilic Esophagitis in Phase 3 Trial
July 20th 2022Dupilumab (Dupixent) is the first medicine to improve signs of eosinophilic esophagitis and support weight gain in children ages 1 to 11, for whom there are no currently approved treatments.
Read More